New Leaf Venture Partners, L.L.C. Edgewise Therapeutics, Inc. Transaction History
New Leaf Venture Partners, L.L.C.
- $82.1 Million
- Q2 2024
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 1,553,661 shares of EWTX stock, worth $44.1 Million. This represents 34.08% of its overall portfolio holdings.
Number of Shares
1,553,661
Previous 1,553,661
-0.0%
Holding current value
$44.1 Million
Previous $28.3 Million
1.26%
% of portfolio
34.08%
Previous 24.84%
Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
144Shares Held
96.7MCall Options Held
45.7KPut Options Held
5.3K-
Orbimed Advisors LLC San Diego, CA15MShares$427 Million6.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$253 Million2.42% of portfolio
-
Novo Holdings Hellerup, G76.34MShares$180 Million8.16% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$171 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$166 Million1.4% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.79B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...